---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004428"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T04:49:37.522639+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Indaptus receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period

## Summary
- Received Nasdaq notice on Jan 31, 2025 for non-compliance with minimum bid price of $1.00 per share.
- Bid price below $1.00 for 30 consecutive business days triggered the notice.
- Has 180 calendar days (until July 30, 2025) to regain compliance.
- To cure, closing bid must be at least $1.00 for 10 consecutive business days.
- May consider reverse stock split; second 180-day period available if other standards met.

## SEC filing metadata
- accession: 0001493152-25-004428
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315225004428/0001493152-25-004428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315225004428/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004428
- JSON: https://secwatch.observer/filing/0001493152-25-004428.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004428.txt

## Source-grounded claims
- claim_id: a31f6a42d77afdcbeec2f4c70e826c71ab4a5bf2
  claim: Indaptus Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: January 31, 2025, Indaptus Therapeutics, Inc. (the “Company”) was notified (the “Notification Letter”) by the Nasdaq Listing Qualifications (“Nasdaq”) that it is not in compliance with the minimum bid price requirements
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315225004428/0001493152-25-004428-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.